Though FDA’s 21 CFR 111 Good Manufacturing Practices (GMPs) for Dietary Supplements has been in place for over a decade, the industry continues to be plagued by the complexities of compliance. The establishment of specifications for components, in-process materials, and finished products; and then testing to those specifications has continuously been among the top observations issued by FDA.
EAS Consulting Group’s Robert Fish, Independent Advisor for Quality and Compliance, will review recent FDA observations and Warning Letters to help you gain insight to FDA’s enforcement focus as well as trends in problem areas that your firm can proactively address. When FDA shows up for a surprise inspection, you’ll be ready. Register Today!